- R&D
Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.
Turn Biotechnologies has been able to successfully secure fundraising from global pharmaceutical organizations through an oversubscribed funding round. These include HanAll Biopharma,...Covid-19 Oral Treatment to be developed jointly by Sen-Jam Pharmaceuticals and KVK Tech
According to the partnership, KVK Tech will formulate the oral COVID medication and also offer CMC data. KVK tech...Access to Lumykras increased in the U.K through collaboration between Amgen and NHS
The NHS has reached a landmark agreement with Amgen Pharmaceuticals to expand the distribution of Lumykras, a treatment option for lung cancer....Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics
Santhera Pharmaceuticals and Seal Therapeutics' partnership aims to develop gene therapy for the disease known as LAMA2-deficient congenital muscular dystrophy, or LAMA2...
- Clinical
Pfizer to back Valneva with €91M investment for phase 3 Lyme disease vaccine trial
Pfizer has Valneva’s back in support of the late-phase development of a vaccine for Lyme disease. Pfizer has agreed to invest €90.5M...New Eurocine and Redbiotec partnership for Herpes Vaccine
Redbiotec will receive royalty payments on the net sales of the Herpes Simplex Virus Type 2 (HSV-2) vaccine. Sales will be made...Michigan University and Evgen Pharma to work together on colorectal cancer study
Evgen Pharma and University of Michigan have partnered to evaluate SFX-01, Evgen’s lead asset, on possible anti-tumor effects for colorectal cancer (CRC)....Covid-19 vaccine by Pfizer deemed effective for children below five
Federal health officials claimed last week that Pfizer’s Covid-19 vaccines, in small doses, seem to be effective and safe for children below...
- Manufacturing
$2.1 billion manufacturing expansion planned by Eli Lilly, creating 500 jobs
Eli Lilly is digging into its pockets again soon after injecting $1B into new factory for injectables in North Carolina a few...Bavarian Nordic anticipates revenue hike after multiple international monkeypox vaccine deals
The smallpox vaccine by Bavarian Nordic, a Danish pharmaceutical company, has started to gain momentum as the treatment to monkeypox.Catalent adds another medicine manufacturing expansion to its roster
Just seven years after doubling its oral medicines plant, Catalent strengthens its name as a production powerhouse by further expansion of the...Spikevax COVID-19 Vaccine recalled by Moderna and Rovi
Moderna and Rovi pharmaceuticals have issued a recall of more than 750,000 doses of Spikevax, which is Moderna’s COVID-19 shot due to...
- Commercial
Kyowa Kirin considering asset sales of $1B as focus shifts to PI3K inhibitor advancement
Japanese pharmaceutical company Kyowa Kirin is looking to sell assets worth $1B. According to reports, Kyowa Kirin could possibly be selling off...Alnylam’s RNA drug gets FDA approval as a Pfizer face-off may be expected
Alnylam’s vutrisiran has gotten the green light from FDA, which may also result in a confrontation with Vyndaqel, Pfizer’s hit franchise in...$3.3B takeover agreed between buyer GSK and Affinivax
GlaxoSmithKline (GSK) reached a deal to purchase 100% of Affinivax’s outstanding shares for a total of $3.3B. Affinivax is a biopharmaceutical company...Pfizer to make 23 medicines available for developing countries at low prices
The pharmaceutical giant Pfizer has revealed its plans of making 23 of its patented medicines available to 45 developing countries at low-...
- Technology
Zealand Pharma and Iktos collaborate to develop AI Technology for Peptide drug design
Specialists in artificial intelligence for new drug design, Iktos announced a research partnership with Zealand Pharma to jointly develop predictive and generative...Meta Pharmaceutical secures $15 million investment to fund artificial intelligence-based autoimmune treatment
Meta Pharmaceuticals is a Chinese Biotechnology company that has recently completed its pre-A and seed rounds. The company has managed to raise...Catalent and MigVax reach an agreement to develop an oral vaccine for Covid-19
Catalent, a pharmaceutical company based in Somerset, New Jersey has reached an agreement with MigVax, an Israel-based biopharmaceutical firm. The agreement enables...Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion
United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a contract with Chinese Pharmaceutical Company...
- Regulatory
UK’s NICE makes recommendation for Imlifidase by Hansa Biopharmaceutical
With the National Institute for Health and Care Excellence’s (NICE) recommendation for the use of imlifdase, over 100 kidney transplant recipients will...Heart failure drug by Cytokinetics delayed – FDA wants more time to review
The Food and Drug Administration requires more time to study Cytokinetics’ omecamtiv mecarbil following analysis of some additional data.U.S. FDA reject anemia drug Evrenzo approved by UK’s NICE 
Fibrogen and Astellas’ anemia medicine; Evrenzo, had been rejected by the U.S. Food and Drug Administration (FDA) previously. However, the partners have...Novavax COVID-19 moves one step closer to FDA approval
The U.S. Food and Drug Authority’s (FDA) committee has unanimously voted to recommend Novavax’s Covid vaccine for authorized use in the U.S....
- Insights
- More
- R&D
Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.
Turn Biotechnologies has been able to successfully secure fundraising from global pharmaceutical organizations through an oversubscribed funding round. These include HanAll Biopharma,...Covid-19 Oral Treatment to be developed jointly by Sen-Jam Pharmaceuticals and KVK Tech
According to the partnership, KVK Tech will formulate the oral COVID medication and also offer CMC data. KVK tech...Access to Lumykras increased in the U.K through collaboration between Amgen and NHS
The NHS has reached a landmark agreement with Amgen Pharmaceuticals to expand the distribution of Lumykras, a treatment option for lung cancer....Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics
Santhera Pharmaceuticals and Seal Therapeutics' partnership aims to develop gene therapy for the disease known as LAMA2-deficient congenital muscular dystrophy, or LAMA2...
- Clinical
Pfizer to back Valneva with €91M investment for phase 3 Lyme disease vaccine trial
Pfizer has Valneva’s back in support of the late-phase development of a vaccine for Lyme disease. Pfizer has agreed to invest €90.5M...New Eurocine and Redbiotec partnership for Herpes Vaccine
Redbiotec will receive royalty payments on the net sales of the Herpes Simplex Virus Type 2 (HSV-2) vaccine. Sales will be made...Michigan University and Evgen Pharma to work together on colorectal cancer study
Evgen Pharma and University of Michigan have partnered to evaluate SFX-01, Evgen’s lead asset, on possible anti-tumor effects for colorectal cancer (CRC)....Covid-19 vaccine by Pfizer deemed effective for children below five
Federal health officials claimed last week that Pfizer’s Covid-19 vaccines, in small doses, seem to be effective and safe for children below...
- Manufacturing
$2.1 billion manufacturing expansion planned by Eli Lilly, creating 500 jobs
Eli Lilly is digging into its pockets again soon after injecting $1B into new factory for injectables in North Carolina a few...Bavarian Nordic anticipates revenue hike after multiple international monkeypox vaccine deals
The smallpox vaccine by Bavarian Nordic, a Danish pharmaceutical company, has started to gain momentum as the treatment to monkeypox.Catalent adds another medicine manufacturing expansion to its roster
Just seven years after doubling its oral medicines plant, Catalent strengthens its name as a production powerhouse by further expansion of the...Spikevax COVID-19 Vaccine recalled by Moderna and Rovi
Moderna and Rovi pharmaceuticals have issued a recall of more than 750,000 doses of Spikevax, which is Moderna’s COVID-19 shot due to...
- Commercial
- AllBrand & MarketingClinicalCommercialFeaturedInsightsITManufacturingNewsRegulatoryResearch & Development
Kyowa Kirin considering asset sales of $1B as focus shifts to PI3K inhibitor advancement
Japanese pharmaceutical company Kyowa Kirin is looking to sell assets worth $1B. According to reports, Kyowa Kirin could possibly be selling off...Alnylam’s RNA drug gets FDA approval as a Pfizer face-off may be expected
Alnylam’s vutrisiran has gotten the green light from FDA, which may also result in a confrontation with Vyndaqel, Pfizer’s hit franchise in...$3.3B takeover agreed between buyer GSK and Affinivax
GlaxoSmithKline (GSK) reached a deal to purchase 100% of Affinivax’s outstanding shares for a total of $3.3B. Affinivax is a biopharmaceutical company...
- Technology
Zealand Pharma and Iktos collaborate to develop AI Technology for Peptide drug design
Specialists in artificial intelligence for new drug design, Iktos announced a research partnership with Zealand Pharma to jointly develop predictive and generative...Meta Pharmaceutical secures $15 million investment to fund artificial intelligence-based autoimmune treatment
Meta Pharmaceuticals is a Chinese Biotechnology company that has recently completed its pre-A and seed rounds. The company has managed to raise...Catalent and MigVax reach an agreement to develop an oral vaccine for Covid-19
Catalent, a pharmaceutical company based in Somerset, New Jersey has reached an agreement with MigVax, an Israel-based biopharmaceutical firm. The agreement enables...Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion
United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a contract with Chinese Pharmaceutical Company...
- Regulatory
UK’s NICE makes recommendation for Imlifidase by Hansa Biopharmaceutical
With the National Institute for Health and Care Excellence’s (NICE) recommendation for the use of imlifdase, over 100 kidney transplant recipients will...Heart failure drug by Cytokinetics delayed – FDA wants more time to review
The Food and Drug Administration requires more time to study Cytokinetics’ omecamtiv mecarbil following analysis of some additional data.U.S. FDA reject anemia drug Evrenzo approved by UK’s NICE 
Fibrogen and Astellas’ anemia medicine; Evrenzo, had been rejected by the U.S. Food and Drug Administration (FDA) previously. However, the partners have...Novavax COVID-19 moves one step closer to FDA approval
The U.S. Food and Drug Authority’s (FDA) committee has unanimously voted to recommend Novavax’s Covid vaccine for authorized use in the U.S....
- Insights
- More
Manufacturing & RegulatoryPOPULAR
Editor Picks
Amgen to buy Teneobio for $2.5B to further its antibody interests
Amgen isn’t leaning on its laurels even after getting a prompt approval...
Meta Pharmaceutical secures $15 million investment to fund artificial intelligence-based autoimmune treatment
Meta Pharmaceuticals is a Chinese Biotechnology company that has recently completed its...
U.S. to buy additional $1B of Merck’s Covid-19 drug
In the latest Merck’s COVID-19 news, it was reported that President Biden’s...